Literature DB >> 18717813

Differential migration, LPS-induced cytokine, chemokine, and NO expression in immortalized BV-2 and HAPI cell lines and primary microglial cultures.

Ryan J Horvath1, Nancy Nutile-McMenemy, Matthew S Alkaitis, Joyce A Deleo.   

Abstract

Microglial cells are hematopoietically derived monocytes of the CNS and serve important neuromodulatory, neurotrophic, and neuroimmune roles. Following insult to the CNS, microglia develop a reactive phenotype, migrate to the site of injury, proliferate, and release a range of proinflammatory, anti-inflammatory, and neurotrophic factors. Isolation of primary microglial cell cultures has been an integral step in elucidating the many roles of these cells. In addition to primary microglial cells, several immortalized cell lines have been created to model primary microglia in vitro, including murine-derived BV-2 cells and rat derived highly aggressive proliferating immortalized (HAPI) cells. Here, we compare rat primary microglial, BV-2, and HAPI cells in experiments assessing migration, expression of activation markers, and production and release of nitric oxide, cytokines, and chemokines. BV-2 and HAPI cells responded similarly to primary microglia in experiments assessing migration, ionized calcium binding adaptor molecule 1 expression, and nitric oxide release. However, BV-2 and HAPI cells did not model primary microglia in experiments assessing tumor necrosis factor-alpha, interleukin-1beta, interleukin-6, and monocyte chemoattractant protein-1 expression and release and phospho-extracellular signal-regulated kinase 44/42 expression following lipopolysaccharide treatment. These results indicate that BV-2 and HAPI cell cultures only partially model primary microglia and that their use should therefore be carefully considered.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18717813      PMCID: PMC2581646          DOI: 10.1111/j.1471-4159.2008.05633.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  37 in total

1.  Investigating the natural course and treatment of vascular dementia and Alzheimer's disease. Parallel study populations in two randomized, placebo-controlled trials.

Authors:  B Kittner; P P De Deyn; T Erkinjuntti
Journal:  Ann N Y Acad Sci       Date:  2000-04       Impact factor: 5.691

Review 2.  Microglia: activation and their significance in the central nervous system.

Authors:  K Nakajima; S Kohsaka
Journal:  J Biochem       Date:  2001-08       Impact factor: 3.387

3.  Biochemical analysis of proteasomes from mouse microglia: induction of immunoproteasomes by interferon-gamma and lipopolysaccharide.

Authors:  R Stohwasser; J Giesebrecht; R Kraft; E C Müller; K G Häusler; H Kettenmann; U K Hanisch; P M Kloetzel
Journal:  Glia       Date:  2000-02-15       Impact factor: 7.452

Review 4.  The role of neuroinflammation and neuroimmune activation in persistent pain.

Authors:  J A DeLeo; R P Yezierski
Journal:  Pain       Date:  2001-02-01       Impact factor: 6.961

5.  A differential role for the mitogen-activated protein kinases in lipopolysaccharide signaling: the MEK/ERK pathway is not essential for nitric oxide and interleukin 1beta production.

Authors:  Jyoti J Watters; Julie A Sommer; Zachary A Pfeiffer; Usha Prabhu; Alma N Guerra; Paul J Bertics
Journal:  J Biol Chem       Date:  2002-01-10       Impact factor: 5.157

6.  Characterization of a novel brain-derived microglial cell line isolated from neonatal rat brain.

Authors:  P Cheepsunthorn; L Radov; S Menzies; J Reid; J R Connor
Journal:  Glia       Date:  2001-07       Impact factor: 7.452

7.  Isolation and characterization of apolipoproteins from murine microglia. Identification of a low density lipoprotein-like apolipoprotein J-rich but E-poor spherical particle.

Authors:  Q Xu; Y Li; C Cyras; D A Sanan; B Cordell
Journal:  J Biol Chem       Date:  2000-10-13       Impact factor: 5.157

8.  Effect of lipopolysaccharide on the morphology and integrin immunoreactivity of ramified microglia in the mouse brain and in cell culture.

Authors:  C U Kloss; M Bohatschek; G W Kreutzberg; G Raivich
Journal:  Exp Neurol       Date:  2001-03       Impact factor: 5.330

9.  Activated microglia (BV-2) facilitation of TNF-alpha-mediated motor neuron death in vitro.

Authors:  Bei Ping He; Weiyan Wen; Michael J Strong
Journal:  J Neuroimmunol       Date:  2002-07       Impact factor: 3.478

10.  A pilot clinical trial of creatine and minocycline in early Parkinson disease: 18-month results.

Authors: 
Journal:  Clin Neuropharmacol       Date:  2008 May-Jun       Impact factor: 1.592

View more
  101 in total

1.  Cannabinoid CB(2) receptors modulate ERK-1/2 kinase signalling and NO release in microglial cells stimulated with bacterial lipopolysaccharide.

Authors:  Stefania Merighi; Stefania Gessi; Katia Varani; Carolina Simioni; Debora Fazzi; Prisco Mirandola; Pier Andrea Borea
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

2.  Oxidative stress induces release of 2'-AMP from microglia.

Authors:  Travis C Jackson; Shawn E Kotermanski; Patrick M Kochanek; Edwin K Jackson
Journal:  Brain Res       Date:  2018-11-03       Impact factor: 3.252

3.  Leucine-rich repeat kinase 2 modulates neuroinflammation and neurotoxicity in models of human immunodeficiency virus 1-associated neurocognitive disorders.

Authors:  Jenna M Puccini; Daniel F Marker; Tim Fitzgerald; Justin Barbieri; Christopher S Kim; Patrick Miller-Rhodes; Shao-Ming Lu; Stephen Dewhurst; Harris A Gelbard
Journal:  J Neurosci       Date:  2015-04-01       Impact factor: 6.167

4.  Salidroside Restores an Anti-inflammatory Endothelial Phenotype by Selectively Inhibiting Endothelial Complement After Oxidative Stress.

Authors:  Y Wang; Y Su; W Lai; X Huang; K Chu; J Brown; G Hong
Journal:  Inflammation       Date:  2020-02       Impact factor: 4.092

5.  Cannabinoids inhibit migration of microglial-like cells to the HIV protein Tat.

Authors:  Daniel Fraga; Erinn S Raborn; Gabriela A Ferreira; Guy A Cabral
Journal:  J Neuroimmune Pharmacol       Date:  2011-07-07       Impact factor: 4.147

6.  Morphine enhances microglial migration through modulation of P2X4 receptor signaling.

Authors:  Ryan J Horvath; Joyce A DeLeo
Journal:  J Neurosci       Date:  2009-01-28       Impact factor: 6.167

Review 7.  NADPH oxidase- and mitochondria-derived reactive oxygen species in proinflammatory microglial activation: a bipartisan affair?

Authors:  Evan A Bordt; Brian M Polster
Journal:  Free Radic Biol Med       Date:  2014-08-01       Impact factor: 7.376

8.  Suppressed pro-inflammatory response of microglia in CX3CR1 knockout mice.

Authors:  Hayley A Mattison; Hui Nie; Huiming Gao; Hui Zhou; Jau-Shyong Hong; Jing Zhang
Journal:  J Neuroimmunol       Date:  2013-03-15       Impact factor: 3.478

9.  TGF-beta1 blockade of microglial chemotaxis toward Abeta aggregates involves SMAD signaling and down-regulation of CCL5.

Authors:  Wei-Chao Huang; Feng-Chang Yen; Feng-Shiun Shie; Chih-Ming Pan; Young-Ji Shiao; Cheng-Ning Yang; Fong-Lee Huang; Yen-Jen Sung; Huey-Jen Tsay
Journal:  J Neuroinflammation       Date:  2010-04-29       Impact factor: 8.322

10.  Cannabinoid receptor type 2 activation induces a microglial anti-inflammatory phenotype and reduces migration via MKP induction and ERK dephosphorylation.

Authors:  Edgar Alfonso Romero-Sandoval; Ryan Horvath; Russell P Landry; Joyce A DeLeo
Journal:  Mol Pain       Date:  2009-05-28       Impact factor: 3.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.